Effects of SGLT‐2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine‐N‐Oxide in Patients With Type‐2 Diabetes

Katja B. Zimmer, Arne Gessner, Dennis Kannenkeril, Agnes Bosch, Armin Ströbel, Roland E. Schmieder, Renke Maas
Endocrinology, Diabetes and Metabolism · Wiley · 2026-10-01 · DOI: 10.1002/edm2.70318

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles